Symbols / CYRX
CYRX Chart
About
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company's Life Sciences Services segment provides temperature-controlled logistics and cryogenic biostorage within the life science industry. Its Life Sciences Products segment offers cryogenic freezers, cryogenic dewars, and accessories within the life science industry through direct sales or a distribution network. The company's products include Cryoport Express Shippers; Cryoport ELITE Shippers; Cryoport Express Cryogenic HV3 Shipping System; Smartpak II Condition Monitoring System and Tec4Med; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as CRYOGENE, a biostorage solution for the provision of pre-clinical temperature-controlled biological materials management services; and Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services, including physical, thermal, and shipping qualifications of shipping systems and/or packaging to developing custom packaging solutions; CRYOPDP, a temperature-controlled logistics solution; MVE Biological Solutions' Fusion cryogenic system, a self-sustaining cryogenic freezer; and Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.
Fundamentals
Scroll to Statements| Sector | Industrials | Industry | Integrated Freight & Log | Market Cap | 414.07M |
| Enterprise Value | 263.89M | Income | -60.67M | Sales | 243.80M |
| Book/sh | 9.45 | Cash/sh | 8.41 | Dividend Yield | — |
| Payout | 0.00% | Employees | 1090 | IPO | — |
| P/E | — | Forward P/E | -12.72 | PEG | — |
| P/S | 1.70 | P/B | 0.88 | P/C | — |
| EV/EBITDA | -13.30 | EV/Sales | 1.08 | Quick Ratio | 14.84 |
| Current Ratio | 15.77 | Debt/Eq | 44.98 | LT Debt/Eq | — |
| EPS (ttm) | -1.22 | EPS next Y | -0.65 | EPS Growth | — |
| Revenue Growth | 15.40% | Earnings | 2026-03-03 | ROA | -4.39% |
| ROE | -11.30% | ROIC | — | Gross Margin | 45.45% |
| Oper. Margin | -22.01% | Profit Margin | 29.23% | Shs Outstand | 50.07M |
| Shs Float | 40.21M | Short Float | 6.66% | Short Ratio | 8.27 |
| Short Interest | — | 52W High | 11.45 | 52W Low | 4.58 |
| Beta | 1.68 | Avg Volume | 405.20K | Volume | 268.22K |
| Target Price | $13.22 | Recom | None | Prev Close | $8.14 |
| Price | $8.27 | Change | 1.60% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2025-11-05 | main | UBS | Buy → Buy | $13 |
| 2025-11-05 | main | Needham | Buy → Buy | $12 |
| 2025-09-18 | main | BTIG | Buy → Buy | $15 |
| 2025-08-06 | up | Leerink Partners | Market Perform → Outperform | $16 |
| 2025-08-06 | up | Keybanc | Sector Weight → Overweight | $15 |
| 2025-07-07 | main | BTIG | Buy → Buy | $10 |
| 2025-05-08 | reit | Needham | Buy → Buy | $11 |
| 2025-05-05 | main | Morgan Stanley | Equal-Weight → Equal-Weight | $7 |
| 2025-04-16 | reit | Needham | Buy → Buy | $11 |
| 2025-04-16 | reit | Guggenheim | Buy → Buy | $10 |
| 2025-04-10 | reit | Needham | Buy → Buy | $11 |
| 2025-04-01 | reit | Roth MKM | Buy → Buy | $15 |
| 2025-04-01 | main | UBS | Buy → Buy | $11 |
| 2025-04-01 | reit | Needham | Buy → Buy | $11 |
| 2025-03-31 | reit | Needham | Buy → Buy | $11 |
| 2025-03-24 | up | UBS | Neutral → Buy | $10 |
| 2025-03-05 | reit | Needham | Buy → Buy | $11 |
| 2025-01-17 | reit | Needham | Buy → Buy | $11 |
| 2024-11-08 | main | Roth MKM | Buy → Buy | $15 |
| 2024-10-18 | main | UBS | Neutral → Neutral | $9 |
- CryoPort (CYRX) to Release Quarterly Earnings on Tuesday - MarketBeat ue, 24 Feb 2026 11
- Cryoport Reports Third Quarter 2025 Financial Results - PR Newswire ue, 04 Nov 2025 08
- Cryoport’s new lab freezer runs without continuous liquid nitrogen - Stock Titan Wed, 11 Feb 2026 08
- (CYRX) and the Role of Price-Sensitive Allocations - Stock Traders Daily Fri, 20 Feb 2026 11
- $CYRX stock is down 10% today. Here's what we see in our data. - Quiver Quantitative ue, 28 Oct 2025 07
- Improved Revenues Required Before Cryoport, Inc. (NASDAQ:CYRX) Shares Find Their Feet - simplywall.st ue, 22 Jul 2025 07
- CryoPort, Inc. (CYRX) Reports Q3 Loss, Tops Revenue Estimates - Nasdaq ue, 04 Nov 2025 08
- Earnings To Watch: CryoPort Inc (CYRX) Reports Q3 2025 Result - Yahoo Finance Mon, 03 Nov 2025 08
- CEO Jerrell Shelton Sells Some Shares of Cryoport (CYRX) - The Motley Fool Mon, 30 Jun 2025 07
- CryoPort Inc (CYRX) Shares Down 2.89% on Jan 23 - GuruFocus Fri, 23 Jan 2026 08
- Readystate Asset Management LP Sells 180,605 Shares of CryoPort, Inc. $CYRX - MarketBeat Wed, 18 Feb 2026 09
- CryoPort stock price target raised to $15 from $10 at BTIG - Investing.com hu, 18 Sep 2025 07
- Responsive Playbooks and the CYRX Inflection - Stock Traders Daily Mon, 09 Feb 2026 08
- Is Cryoport, Inc. (CYRX) a Pump and Dump Stock Favored by Hedge Funds? - Yahoo Finance ue, 18 Mar 2025 07
- Cryoport (NASDAQ:CYRX) shareholders are up 10% this past week, but still in the red over the last five years - simplywall.st Sun, 11 Jan 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 11570 | 115540.0 | — | Sale at price 9.99 per share. | MANDALAM RAMKUMAR | Director | — | 2025-12-10 00:00:00 | D |
| 1 | 25000 | 242738.0 | — | Sale at price 9.71 per share. | HARIRI ROBERT J | Director | — | 2025-09-11 00:00:00 | D |
| 2 | 50000 | 133000.0 | — | Conversion of Exercise of derivative security at price 2.66 per share. | HARIRI ROBERT J | Director | — | 2025-09-11 00:00:00 | D |
| 3 | 5000 | 43000.0 | — | Sale at price 8.60 per share. | HARIRI ROBERT J | Director | — | 2025-08-22 00:00:00 | D |
| 4 | 9300 | 80618.0 | — | Sale at price 8.67 per share. | STEFANOVICH ROBERT STEVEN | Chief Financial Officer | — | 2025-08-19 00:00:00 | D |
| 5 | 26164 | 80323.0 | — | Conversion of Exercise of derivative security at price 3.07 per share. | STEFANOVICH ROBERT STEVEN | Chief Financial Officer | — | 2025-08-19 00:00:00 | D |
| 6 | 25000 | 125000.0 | — | Conversion of Exercise of derivative security at price 5.00 per share. | SHELTON JERRELL WILSON | Chief Executive Officer | — | 2025-08-13 00:00:00 | D |
| 7 | 25000 | 125000.0 | — | Conversion of Exercise of derivative security at price 5.00 per share. | SHELTON JERRELL WILSON | Chief Executive Officer | — | 2025-07-31 00:00:00 | D |
| 8 | 25000 | 125000.0 | — | Conversion of Exercise of derivative security at price 5.00 per share. | SHELTON JERRELL WILSON | Chief Executive Officer | — | 2025-07-24 00:00:00 | D |
| 9 | 40728 | 294899.0 | — | Sale at price 7.24 per share. | MANDALAM RAMKUMAR | Director | — | 2025-07-22 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -7.44M | -7.00M | 1.78M | -67.10M |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.27 |
| NormalizedEBITDA | -43.21M | -33.05M | -14.66M | -405.00K |
| TotalUnusualItems | -35.41M | -33.31M | 8.47M | -248.50M |
| TotalUnusualItemsExcludingGoodwill | -35.41M | -33.31M | 8.47M | -248.50M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -114.76M | -99.59M | -37.33M | -275.53M |
| ReconciledDepreciation | 30.76M | 27.49M | 22.77M | 20.25M |
| ReconciledCostOfRevenue | 128.75M | 133.92M | 133.40M | 126.03M |
| EBITDA | -78.61M | -66.36M | -6.19M | -248.91M |
| EBIT | -109.37M | -93.84M | -28.95M | -269.15M |
| NetInterestIncome | -4.11M | -5.50M | -6.14M | -4.69M |
| InterestExpense | 4.11M | 5.50M | 6.14M | 4.69M |
| NormalizedIncome | -86.78M | -73.27M | -44.03M | -94.12M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -114.76M | -99.59M | -37.33M | -275.53M |
| TotalExpenses | 295.44M | 298.84M | 269.18M | 240.44M |
| TotalOperatingIncomeAsReported | -130.87M | -115.16M | -31.90M | -17.83M |
| DilutedAverageShares | 49.35M | 48.74M | 48.99M | 45.93M |
| BasicAverageShares | 49.35M | 48.74M | 48.99M | 45.93M |
| DilutedEPS | -2.49 | -2.21 | -0.93 | -6.18 |
| BasicEPS | -2.49 | -2.21 | -0.93 | -6.18 |
| DilutedNIAvailtoComStockholders | -122.76M | -107.59M | -45.33M | -283.72M |
| NetIncomeCommonStockholders | -122.76M | -107.59M | -45.33M | -283.72M |
| PreferredStockDividends | 8.00M | 8.00M | 8.00M | 8.20M |
| NetIncome | -114.76M | -99.59M | -37.33M | -275.53M |
| NetIncomeIncludingNoncontrollingInterests | -114.76M | -99.59M | -37.33M | -275.53M |
| NetIncomeContinuousOperations | -114.76M | -99.59M | -37.33M | -275.53M |
| TaxProvision | 1.28M | 239.00K | 2.24M | 1.69M |
| PretaxIncome | -113.48M | -99.35M | -35.09M | -273.84M |
| OtherIncomeExpense | -42.31M | -28.26M | 2.95M | -251.32M |
| OtherNonOperatingIncomeExpenses | -6.91M | 5.06M | -5.52M | -2.82M |
| SpecialIncomeCharges | -45.30M | -43.89M | 0.00 | -251.75M |
| OtherSpecialCharges | -18.50M | -5.68M | 251.75M | |
| ImpairmentOfCapitalAssets | 63.81M | 49.57M | 0.00 | 0.00 |
| GainOnSaleOfSecurity | 9.89M | 10.58M | 8.47M | 3.25M |
| NetNonOperatingInterestIncomeExpense | -4.11M | -5.50M | -6.14M | -4.69M |
| InterestExpenseNonOperating | 4.11M | 5.50M | 6.14M | 4.69M |
| OperatingIncome | -67.06M | -65.59M | -31.90M | -17.83M |
| OperatingExpense | 166.69M | 164.92M | 135.78M | 114.41M |
| ResearchAndDevelopment | 17.71M | 18.04M | 15.72M | 16.84M |
| SellingGeneralAndAdministration | 148.98M | 146.88M | 120.06M | 97.56M |
| GrossProfit | 99.63M | 99.33M | 103.87M | 96.58M |
| CostOfRevenue | 128.75M | 133.92M | 133.40M | 126.03M |
| TotalRevenue | 228.38M | 233.25M | 237.28M | 222.61M |
| OperatingRevenue | 228.38M | 233.25M | 237.28M | 222.61M |
| Line Item | 2022-12-31 | |||
|---|---|---|---|---|
| PreferredSharesNumber | 200.00K | |||
| OrdinarySharesNumber | 49.91M | 48.97M | 48.33M | 49.62M |
| ShareIssued | 49.91M | 48.97M | 48.33M | 49.62M |
| NetDebt | 154.19M | 333.69M | 370.53M | 266.16M |
| TotalDebt | 250.70M | 416.00M | 435.91M | 427.06M |
| TangibleBookValue | 145.50M | 159.96M | 195.44M | 283.17M |
| InvestedCapital | 567.10M | 842.78M | 944.69M | 1.04B |
| WorkingCapital | 277.01M | 489.50M | 563.33M | 650.87M |
| NetTangibleAssets | 179.77M | 186.24M | 213.71M | 293.45M |
| CapitalLeaseObligations | 51.23M | 35.97M | 28.79M | 21.80M |
| CommonStockEquity | 367.62M | 462.75M | 537.56M | 631.55M |
| PreferredStockEquity | 34.27M | 26.27M | 18.27M | 10.28M |
| TotalCapitalization | 586.93M | 868.91M | 962.90M | 1.05B |
| TotalEquityGrossMinorityInterest | 401.90M | 489.02M | 555.84M | 641.83M |
| StockholdersEquity | 401.90M | 489.02M | 555.84M | 641.83M |
| GainsLossesNotAffectingRetainedEarnings | -20.93M | -26.07M | -34.55M | -1.24M |
| OtherEquityAdjustments | -20.93M | -26.07M | -34.55M | -1.24M |
| RetainedEarnings | -757.17M | -642.42M | -542.83M | -467.54M |
| AdditionalPaidInCapital | 1.15B | 1.13B | 1.11B | 1.10B |
| CapitalStock | 34.33M | 26.32M | 18.32M | 10.32M |
| CommonStock | 50.00K | 49.00K | 48.00K | 50.00K |
| PreferredStock | 34.27M | 26.27M | 18.27M | 10.28M |
| TotalLiabilitiesNetMinorityInterest | 301.59M | 468.72M | 482.91M | 471.14M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 237.03M | 423.11M | 442.06M | 428.50M |
| OtherNonCurrentLiabilities | 4.14M | 10.10M | 5.13M | 1.03M |
| NonCurrentDeferredLiabilities | 2.53M | 2.82M | 4.93M | 4.02M |
| NonCurrentDeferredTaxesLiabilities | 2.53M | 2.82M | 4.93M | 4.02M |
| LongTermDebtAndCapitalLeaseObligation | 230.35M | 410.20M | 432.00M | 423.45M |
| LongTermCapitalLeaseObligation | 45.32M | 30.31M | 24.94M | 18.20M |
| LongTermDebt | 185.03M | 379.89M | 407.06M | 405.26M |
| CurrentLiabilities | 64.56M | 45.61M | 40.85M | 42.65M |
| OtherCurrentLiabilities | 2.81M | 92.00K | ||
| CurrentDeferredLiabilities | 1.11M | 1.31M | 439.00K | 547.00K |
| CurrentDeferredRevenue | 1.11M | 1.31M | 439.00K | 547.00K |
| CurrentDebtAndCapitalLeaseObligation | 20.35M | 5.81M | 3.91M | 3.60M |
| CurrentCapitalLeaseObligation | 5.91M | 5.66M | 3.85M | 3.60M |
| CurrentDebt | 14.44M | 149.00K | 60.00K | |
| OtherCurrentBorrowings | 14.44M | 149.00K | 60.00K | |
| PensionandOtherPostRetirementBenefitPlansCurrent | 3.06M | 2.77M | 2.45M | 1.91M |
| PayablesAndAccruedExpenses | 37.24M | 35.63M | 34.05M | 36.59M |
| CurrentAccruedExpenses | 10.03M | 8.64M | 6.01M | 8.00M |
| Payables | 27.21M | 27.00M | 28.05M | 28.58M |
| AccountsPayable | 27.21M | 27.00M | 28.05M | 28.58M |
| TotalAssets | 703.49M | 957.74M | 1.04B | 1.11B |
| TotalNonCurrentAssets | 361.92M | 422.63M | 434.57M | 419.45M |
| OtherNonCurrentAssets | 419.00K | |||
| NonCurrentPrepaidAssets | 2.90M | 1.68M | 1.02M | 950.00K |
| NonCurrentDeferredAssets | 868.00K | 656.00K | 947.00K | 419.00K |
| NonCurrentDeferredTaxesAssets | 868.00K | 656.00K | 947.00K | 419.00K |
| GoodwillAndOtherIntangibleAssets | 222.12M | 302.79M | 342.13M | 348.38M |
| OtherIntangibleAssets | 170.46M | 194.38M | 191.01M | 201.43M |
| Goodwill | 51.66M | 108.40M | 151.12M | 146.95M |
| NetPPE | 136.03M | 117.51M | 90.48M | 69.70M |
| AccumulatedDepreciation | -45.87M | -36.59M | -27.34M | -20.00M |
| GrossPPE | 181.89M | 154.10M | 117.81M | 89.70M |
| Leases | 39.49M | 33.69M | 27.08M | 21.66M |
| ConstructionInProgress | 27.15M | 24.22M | 15.95M | 8.58M |
| OtherProperties | 72.84M | 55.82M | 45.57M | 35.36M |
| MachineryFurnitureEquipment | 32.02M | 31.02M | 23.08M | 16.99M |
| BuildingsAndImprovements | 6.81M | 6.65M | 4.47M | 5.81M |
| LandAndImprovements | 813.00K | 813.00K | 813.00K | 806.00K |
| CurrentAssets | 341.57M | 535.11M | 604.18M | 693.52M |
| OtherCurrentAssets | 11.57M | 10.08M | 9.32M | 8.80M |
| PrepaidAssets | 8.80M | |||
| Inventory | 22.47M | 26.21M | 27.68M | 16.50M |
| Receivables | 45.78M | 42.07M | 43.86M | 39.41M |
| AccountsReceivable | 45.78M | 42.07M | 43.86M | 39.41M |
| AllowanceForDoubtfulAccountsReceivable | -1.80M | -2.00M | -1.30M | -1.20M |
| GrossAccountsReceivable | 47.58M | 44.07M | 45.16M | 40.61M |
| CashCashEquivalentsAndShortTermInvestments | 261.75M | 456.75M | 523.32M | 628.80M |
| OtherShortTermInvestments | 216.46M | 410.41M | 486.73M | 489.70M |
| CashAndCashEquivalents | 45.29M | 46.35M | 36.59M | 139.10M |
| CashEquivalents | 134.00K | 5.37M | 1.84M | 111.31M |
| CashFinancial | 45.16M | 40.98M | 34.75M | 27.79M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | -37.59M | -45.66M | -26.05M | -16.88M |
| RepurchaseOfCapitalStock | 0.00 | 0.00 | -37.96M | 0.00 |
| RepaymentOfDebt | -164.32M | -25.28M | -3.26M | -3.46M |
| IssuanceOfDebt | 0.00 | 0.00 | 40.07M | |
| IssuanceOfCapitalStock | 0.00 | 0.00 | 518.74M | |
| CapitalExpenditure | -21.27M | -44.90M | -24.20M | -25.01M |
| InterestPaidSupplementalData | 2.69M | 3.40M | 3.63M | 3.30M |
| IncomeTaxPaidSupplementalData | 1.42M | 1.46M | 1.98M | 1.31M |
| EndCashPosition | 45.29M | 46.35M | 36.59M | 139.10M |
| BeginningCashPosition | 46.35M | 36.59M | 139.10M | 36.87M |
| EffectOfExchangeRateChanges | -18.00K | -1.74M | -1.80M | -986.00K |
| ChangesInCash | -1.04M | 11.49M | -100.71M | 103.21M |
| FinancingCashFlow | -161.53M | -23.80M | -39.17M | 564.34M |
| CashFlowFromContinuingFinancingActivities | -161.53M | -23.80M | -39.17M | 564.34M |
| ProceedsFromStockOptionExercised | 2.79M | 1.48M | 2.05M | 8.99M |
| NetPreferredStockIssuance | 0.00 | 0.00 | 248.91M | |
| PreferredStockIssuance | 0.00 | 0.00 | 248.91M | |
| NetCommonStockIssuance | 0.00 | 0.00 | -37.96M | 269.82M |
| CommonStockPayments | 0.00 | 0.00 | -37.96M | 0.00 |
| CommonStockIssuance | 0.00 | 0.00 | 269.82M | |
| NetIssuancePaymentsOfDebt | -164.32M | -25.28M | -3.26M | 36.61M |
| NetLongTermDebtIssuance | -164.32M | -25.28M | -3.26M | 36.61M |
| LongTermDebtPayments | -164.32M | -25.28M | -3.26M | -3.46M |
| LongTermDebtIssuance | 0.00 | 0.00 | 40.07M | |
| InvestingCashFlow | 176.81M | 36.05M | -59.68M | -469.25M |
| CashFlowFromContinuingInvestingActivities | 176.81M | 36.05M | -59.68M | -469.25M |
| NetOtherInvestingChanges | 976.00K | 3.00M | ||
| NetInvestmentPurchaseAndSale | 198.40M | 87.31M | -31.93M | -438.71M |
| SaleOfInvestment | 249.12M | 129.99M | 131.86M | 44.00M |
| PurchaseOfInvestment | -50.72M | -42.68M | -163.79M | -482.71M |
| NetBusinessPurchaseAndSale | -313.00K | -7.34M | -6.55M | -5.54M |
| PurchaseOfBusiness | -313.00K | -7.34M | -6.55M | -5.54M |
| NetIntangiblesPurchaseAndSale | -4.01M | -6.12M | -2.09M | -1.12M |
| PurchaseOfIntangibles | -4.01M | -6.12M | -2.09M | -1.12M |
| NetPPEPurchaseAndSale | -17.25M | -38.78M | -22.11M | -23.88M |
| PurchaseOfPPE | -17.25M | -38.78M | -22.11M | -23.88M |
| OperatingCashFlow | -16.32M | -757.00K | -1.85M | 8.13M |
| CashFlowFromContinuingOperatingActivities | -16.32M | -757.00K | -1.85M | 8.13M |
| ChangeInWorkingCapital | -8.61M | -1.20M | -32.07M | -10.33M |
| ChangeInOtherWorkingCapital | -556.00K | -1.14M | -941.00K | 333.00K |
| ChangeInOtherCurrentLiabilities | -5.34M | -4.59M | -3.08M | -2.81M |
| ChangeInPayablesAndAccruedExpense | 1.78M | 118.00K | -8.05M | 2.12M |
| ChangeInAccruedExpense | 1.85M | 2.88M | -1.57M | 2.52M |
| ChangeInPayable | -76.00K | -2.77M | -6.48M | -398.00K |
| ChangeInAccountPayable | -76.00K | -2.77M | -6.48M | -398.00K |
| ChangeInPrepaidAssets | -3.59M | -766.00K | -1.66M | 3.27M |
| ChangeInInventory | 3.25M | 1.51M | -14.20M | -5.98M |
| ChangeInReceivables | -4.15M | 3.67M | -4.14M | -7.27M |
| ChangesInAccountReceivables | -4.15M | 3.67M | -4.14M | -7.27M |
| OtherNonCashItems | 5.86M | 6.13M | 12.39M | 4.60M |
| StockBasedCompensation | 19.70M | 22.81M | 20.08M | 15.35M |
| UnrealizedGainLossOnInvestmentSecurities | 899.00K | -1.31M | 11.41M | 1.39M |
| ProvisionandWriteOffofAssets | 822.00K | 234.00K | 26.00K | |
| AssetImpairmentCharge | 63.81M | 49.57M | 0.00 | 0.00 |
| DepreciationAmortizationDepletion | 30.76M | 27.49M | 22.77M | 20.25M |
| DepreciationAndAmortization | 30.76M | 27.49M | 22.77M | 20.25M |
| OperatingGainsLosses | -13.98M | -4.66M | 902.00K | 252.38M |
| GainLossOnInvestmentSecurities | 4.14M | 67.00K | 102.00K | 81.00K |
| GainLossOnSaleOfPPE | 384.00K | 954.00K | 800.00K | 542.00K |
| NetIncomeFromContinuingOperations | -114.76M | -99.59M | -37.33M | -275.53M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for CYRX
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|